Actively Recruiting
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
Led by Qilu Hospital of Shandong University · Updated on 2024-10-18
2100
Participants Needed
1
Research Sites
125 weeks
Total Duration
On this page
Sponsors
Q
Qilu Hospital of Shandong University
Lead Sponsor
F
First Affiliated Hospital, Sun Yat-Sen University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective cohort study. The investigators enroll subjects with pancreatic ductal adenocarcinoma (PDAC), individuals at high risk for PDAC, patients with other pancreatic diseases, patients with CA19-9 elevation and controls without pancreatic disease. This study aims to establish a diagnostic prediction model by using elastase 1, common clinical serological examinations, and imaging examinations including endoscopic ultrasonography (EUS), and to explore the diagnostic ability of the model in the high-risk population of PDAC. Besides, the investigators search for new biomarkers by multi-omics studies of serum and pancreatic tissues to further improve the diagnostic performance of this model. In conclusion, this study seeks a robust diagnostic prediction model to diagnose PDAC, especially early resectable PDAC.
CONDITIONS
Official Title
Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with pancreatic cancer diagnosed by recognized criteria
- Patients identified as high-risk for pancreatic cancer
- Patients with solid pseudopapillary tumors or pancreatic neuroendocrine tumors diagnosed by recognized criteria
- Patients with other diseases causing elevated CA19-9 levels
- Control patients without pancreatic disease confirmed by lab tests and imaging and no CA19-9 elevation
You will not qualify if you...
- Patients younger than 18 years old
- Patients suspected of pancreatic malignant lesions without confirmed imaging or pathological diagnosis
- Patients who have not signed informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ning Zhong
Jinan, Shandong, China, 250063
Actively Recruiting
Research Team
Z
Zhen Li, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here